Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.41 |
| ▸ | PGK1 | P00558 | 1/20 | 0.40 |
| ▸ | PGK2 | P07205 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.35 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29204294 | 0.88 | LPAR5 (0.39) | PGDPGK1PGK2LPAR5S1PR2 | |
| SCHEMBL29204260 | 0.86 | LPAR5 (0.44) | PGDLPAR5S1PR2S1PR1S1PR3 | |
| SCHEMBL29204300 | 0.85 | LPAR5 (0.46) | LPAR5S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL28892055 | 0.85 | LPAR5 (0.46) | LPAR5S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL28892066 | 0.81 | PGD (0.45) | PGDPGK1PGK2LPAR5S1PR2 | |
| SCHEMBL25393911 | 0.76 | CYP2C9 (0.31) | PGD | |
| SCHEMBL18007397 | 0.76 | CYP2C9 (0.31) | PGD | |
| SCHEMBL28892063 | 0.75 | PGD (0.42) | PGDPGK1PGK2MPI | |
| SCHEMBL28892075 | 0.75 | PGD (0.39) | PGDPGK1PGK2LPAR5S1PR2 | |
| SCHEMBL28892048 | 0.70 | PGD (0.47) | PGDPGK1PGK2S1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115364110-B | Application of 6-phosphogluconic acid and derivatives thereof in preparation of medicines for preventing or treating sugar metabolic disorder diseases | 复旦大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-115364110-A | Application of 6-phosphogluconic acid and derivatives thereof in preparing medicines for preventing or treating glycometabolism disorder diseases | 复旦大学 | 2022-11-22 | — | — | CN | disclosed |